Advertisement
This annual ranking is based on a companies' five-year revenue growth,for which ApaTech has achieved a rate of 8,318% over this period. Thisachievement places ApaTech 9th overall in the ranking that includes thefastest growing public and private technology, media, telecommunications,life sciences and green technology companies from 26 countries in EMEA.
Advertisement
Simon Cartmell, ApaTech CEO commented: "This award demonstrates that agreat product based on great technology, with a great team behind it canachieve incredible results. The determination to succeed is embedded in thefabric of our business and the people that work here; their passion andambition are the reason for our success."
"Because Deloitte Technology Fast 500 EMEA measures sustained revenuegrowth over five years, being one of the 500 fastest growing technologycompanies in EMEA is an impressive achievement," said David Halstead, partnerin charge of Deloitte's Technology Fast 500 EMEA program. "ApaTech deserves alot of credit for its remarkable growth."
The Deloitte Technology Fast 500 is the most objective industry-rankingstandard to focus on the technology sector. Entrants to the ranking must havebeen in business at least five years and have had base-year operatingrevenues of at least EUR50,000 and current year operating revenues of atleast EUR800,000.
ApaTech is the developer and manufacturer of Actifuse(R), a unique fullysynthetic silicate substituted calcium phosphate bone graft material fororthopaedic, spinal, dental and craniomaxillofacial applications. TheActifuse scaffold mimics the body's natural bony structure and acceleratesthe growth of high quality bone. Actifuse is being used by surgeons in morethan 30 countries around the world.
Notes to Editors:
About ApaTech(R)
ApaTech is a company specializing in synthetic bone repair materials fororthopedic and dental applications. With operations in London, England,Foxborough, Massachusetts, USA, and Berlin, Germany, ApaTech is a worldleader in research and development of bone graft technologies. The companyhas enjoyed strong commercial success globally with products sold in 33countries.
ApaTech has developed and commercialized a novel silicate substitutedcalcium phosphate bone graft material, Actifuse(R). Actifuse is the first ofa new class of synthetic bone graft materials that combine osteoconductive,osteostimulatory and bioactive qualities resulting in accelerated bonegrowth. The Actifuse technology platform exemplifies the Company's leadershipin applying the science of silicon to bone graft technologies. ApaTech isbacked by international investors Encore Ventures and Healthcor and followingits formation in 2001, the Company has raised more than $60m from investors.
ApaTech is committed to delivering shareholder value by using itsscientific leadership to deliver targeted solutions to physicians, allowingthem to significantly improve patient outcomes.
ApaTech has received several corporate business and research awards,including the Frost & Sullivan '2009 North American Device Biologics Companyof the Year' as a result of its success in the US orthobiologics market. Morerecently, ApaTech was awarded 3rd place in the UK Deloitte Technology Fast 50(2009), in addition to being recognized as Britain's fastest growing medicaltechnology company 3 years running in 2009, 2008 and 2007 by the Sunday TimesFast Track 100 fastest growing private technology companies review.
More details can be found at http://www.apatech.com
About Deloitte
"Deloitte" is the brand under which tens of thousands of dedicatedprofessionals in independent firms throughout the world collaborate toprovide audit, consulting, financial advisory, risk management and taxservices to selected clients. These firms are members of Deloitte ToucheTohmatsu, a Swiss Verein ("DTT"). Each member firm provides services in aparticular geographic area and is subject to the laws and professionalregulations of the particular country or countries in which it operates. DTThelps coordinate the activities of the member firms but does not itselfprovide services to clients. DTT and the member firms are separate anddistinct legal entities, which cannot obligate the other entities. DTT andeach DTT member firm are only liable for their own acts or omissions, and notthose of each other. Each DTT Member Firm is structured differently inaccordance with national laws, regulations, customary practice and otherfactors, and may secure the provision of professional services in theirterritories through subsidiaries, affiliates and/or other entities.
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a SwissVerein, and its network of member firms, each of which is a legally separateand independent entity. Please see http://www.deloitte.com/about for adetailed description of the legal structure of Deloitte Touche Tohmatsu andits Member Firms.(c) 2009 Deloitte Touche Tohmatsu. All rights reserved. Further Information: ApaTech Simon Cartmell, CEO +44-20-8731-4640 [email protected] http://www.apatech.com Waughton Robin Hepburn +44-20-7796-9999 [email protected] http://www.waughton.com
SOURCE ApaTech
